Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
Oncoimmunology|January 18, 2021
Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma modelRenske J E van den Bijgaart, Michiel Kroesen, Ingrid C Brok, et al.
Clinical and Translational Radiation Oncology|October 29, 2024
Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor modelsDaan F Boreel, Anne P M Beerkens, Sandra Heskamp, et al.
Blood|February 9, 2008
Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha productionFriederike Meyer-Wentrup, Daniel Benitez-Ribas, Paul J Tacken, et al.
Cancer Immunology Research|September 26, 2022
Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed TumorsJeroen Slaats, Esther Wagena, Daan Smits, et al.
Cancer Immunology, Immunotherapy : CII|March 6, 2010
Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapyGerty Schreibelt, Jurjen Tel, Kwinten H E W J Sliepen, et al.
The Journal of Investigative Dermatology|December 20, 2013
Vitamin D controls murine and human plasmacytoid dendritic cell functionNina Karthaus, Annemiek B van Spriel, Maaike W G Looman, et al.
NMR in Biomedicine|April 11, 2016
In vivo MR guided boiling histotripsy in a mouse tumor model evaluated by MRI and histopathologyMartijn Hoogenboom, Dylan Eikelenboom, Martijn H den Brok, et al.
BMC Immunology|October 8, 2011
DC-STAMP knock-down deregulates cytokine production and T-cell stimulatory capacity of LPS-matured dendritic cellsAnna Sanecka, Marleen Ansems, Amy C Prosser, et al.
International Journal of Cancer|December 14, 2007
Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma modelOliver M Grauer, Roger P M Sutmuller, Wendy van Maren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2026
Mitochondria-targeted OXPHOS inhibition enhances radiotherapy efficacy by disrupting mitochondrial functionAnne P M Beerkens, Paolo S Taracatac, Wenny J M Peeters, et al.
Pageof 23